Showing results (111-120 of 123) with videos related to
Sort By:
Pageof 13
American Heart Journal|July 1, 1994
Cardioprotective effect of the angiotensin II type 1 receptor antagonist TCV-116 on ischemia-reperfusion injuryM Yoshiyama, S Kim, H Yamagishi, et al.Japanese Circulation Journal|November 1, 1995
Angiotensin II type-1 receptor antagonist as well as angiotensin converying enzyme inhibitor attenuates the development of heart failure in aortocaval fistula ratsT Nishikimi, T Tani, T Ohmura, et al.Japanese Circulation Journal|November 1, 1993
Estimation of infarct size using serum troponin T concentration in patients with acute myocardial infarctionT Omura, M Teragaki, T Tani, et al.Biochemical and Biophysical Research Communications|October 12, 2001
Adhesion via CD43 induces Syk activation and cell proliferation in TF-1 cellsY Miura, C Mizutani, T Nishihara, et al.Japanese Circulation Journal|March 1, 1995
Myocardial infarct size by serum troponin T and myosin light chain 1 concentrationT Omura, M Teragaki, M Takagi, et al.The Journal of Biological Chemistry|June 23, 1995
Anti-CD9 monoclonal antibody activates p72syk in human plateletsY Ozaki, K Satoh, K Kuroda, et al.Pediatric Cardiology|March 13, 2002
A simple method for evaluating abnormal lengthening of the QT interval during the face immersion testJ Kamimura, M Yoshinaga, Y Kono, et al.Japanese Circulation Journal|January 1, 1995
Relationship between insufficient redistribution in exercise thallium-201 myocardial single-photon emission computed tomography and reverse redistribution at restH Yamagishi, K Akioka, H Itagane, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 3, 2007
Characterization of urinary peptide biomarkers of acute rejection in renal allograftsE O'Riordan, T N Orlova, V N Podust, et al.Plos Genetics|October 9, 2018
Single copy/knock-in models of ALS SOD1 in C. elegans suggest loss and gain of function have different contributions to cholinergic and glutamatergic neurodegenerationSaba N Baskoylu, Jill Yersak, Patrick O'Hern, et al.Pageof 13